Skip to content

Cancer Antigen 125 (Mucin 16) - Serum/Plasma

Published: August 9, 2026Updated: August 17, 2026

This test measures a protein produced by some cancer cells and certain healthy tissues, often used to monitor ovarian, endometrial, or other gynecologic cancers.

Quick summary

["CA 125 helps track cancer progression and response to treatment."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 17, 2026Editorial policy

Key facts at a glance

LOINC
50782-2
Short code
CA27-29 CSF
Synonyms
Cancer Ag27-29 CSF-aCnc
Category
chemistry
Sample
csf
Container
Sterile CSF collection tube (polypropylene, screw-cap)
Units
N/A
Ref low
0
Ref high
38.6
Critical range
0.5 N/A – —
Fasting
false
Population
adult
Sex
all
Age range
18–99 years
Method
Immunoassay (Chemiluminescent or Radioimmunoassay)
CPT
86316
SNOMED
39470006
Specimen volume
1-2 mL
Stability
Room temperature: 2 hours; Refrigerated (2-8°C): 24 hours; Frozen (-20°C or below): 1 month
Hemolysis max
200
TAT
24–72 hours
Order
routine

What Is CA 125 Used For?

CA 125 is primarily used in the monitoring of ovarian cancer and other gynecologic cancers, such as endometrial cancer. It may also be checked after treatment to see if cancer has returned. However, CA 125 can also be elevated in other conditions, like benign cysts or fibroids, so it’s not definitive on its own.

When Might You Need This Test?

Your doctor may order a CA 125 test if you have symptoms like abdominal pain, bloating, or irregular bleeding, especially if you have a history of ovarian or endometrial cancer. It’s also used as part of follow-up testing after cancer treatment.

What to Expect During the Test

A blood sample is taken from a vein in your arm. You may feel a slight pinch, but it usually doesn’t cause discomfort. The blood is then sent to a lab for analysis.

Possible Results and Next Steps

Results are not always clear-cut. High levels may suggest cancer or other conditions, while low levels may mean cancer is under control. Your doctor will discuss the results in the context of your medical history and other tests.

Reference range

Not normally detectable in cerebrospinal fluid; results should be interpreted in conjunction with clinical findings, imaging, and cytology.N/A

Specimen: csf

No special preparation required. Inform physician of any medications or recent procedures.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

CA 125

Frequently asked questions

Why is CA 125 important in cancer care?
CA 125 is a tumor marker that can indicate the presence of ovarian or endometrial cancer, but it’s not a perfect test. It’s often used alongside imaging and other tests to guide treatment decisions and monitor recurrence.
How does CA 125 compare to other cancer tests?
Unlike some other cancer markers, CA 125 isn’t specific to one type of cancer. It can be elevated in multiple conditions, so doctors rely on it alongside clinical findings and imaging for accurate diagnosis and management.
Can CA 125 levels change over time?
Yes, CA 125 levels can fluctuate. They may rise before cancer spreads or returns and can help track how well treatment is working. However, changes alone don’t always mean cancer is present or gone.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy